WebDisclosure WebDisclosure
Basculer en Français
9992 Companies
202678 Keywords
133282 Articles
107620 Press releases
Headlines Articles Press releases HKeyBio Remove
  1. Home
  2. Companies
  3. HKeyBio
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 09:40, 1 month 10 days ago

    HKeyBio Unveils HKEY-AIRx™1.0 for Asthma and Allergy Drug Development

    Biotech Drug Development Asthma HKeyBio Translational Strategy
  • BRIEF

    published on 01/27/2026 at 09:40, 1 month 10 days ago

    HKeyBio dévoile HKEY-AIRx™ 1.0 pour le développement de médicaments contre l'asthme et les allergies

    Biotechnologie Développement De Médicaments Asthme HKeyBio Stratégie Translationnelle
  • PRESS RELEASE

    published on 01/27/2026 at 09:35, 1 month 10 days ago

    Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

    HKeyBio introduces HKEY-AIRx™1.0, a preclinical strategy to enhance asthma and allergy drug development success by aligning disease endotypes, patient heterogeneity, and translational endpoints
    Drug Development Asthma HKeyBio Allergy Translational Reset
    Logo of HKeyBio
Accesswire
  • Published on 03/06/2026 at 22:00, 20 minutes ago

    Pegasus Resources Inc. Announces Annual General and Special Meeting of Shareholders

  • Published on 03/06/2026 at 17:55, 4 hours 25 minutes ago

    High Tide Resources Announces Upsize to Private Placement

  • Published on 03/06/2026 at 14:00, 8 hours 20 minutes ago

    CHAR Technologies Announces Increase to C$ 3.97M and Closing of Book on Previously Announced Private Placement

  • Published on 03/06/2026 at 14:00, 8 hours 20 minutes ago

    Prospect Ridge Completes Earn in of 100% Ownership of Camelot Copper-Gold Porphyry Project and Readies 2026 Exploration Plan

  • Published on 03/06/2026 at 13:00, 9 hours 20 minutes ago

    Torq Resources Announces Voting Results of Annual General Meeting

View all ACCESSWIRE
EQS Group
  • Published on 03/06/2026 at 19:30, 2 hours 50 minutes ago

    TRADE SHOWS: IEG, OUTSTANDING RESULTS FOR KEY - THE ENERGY TRANSITION EXPO WITH +10% TOTAL VISITORS AND +9% FROM ABROAD

  • Published on 03/06/2026 at 18:44, 3 hours 35 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 03/06/2026 at 18:30, 3 hours 50 minutes ago

    WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care

  • Published on 03/06/2026 at 18:30, 3 hours 50 minutes ago

    Partners Group announces credit rating from Moody's Ratings

  • Published on 03/06/2026 at 18:15, 4 hours 5 minutes ago

    LR Health & Beauty SE advances strategic realignment

View all EQS
Les Echos
  • Published on 03/06/2026 at 18:05, 4 hours 15 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 28/02/2026

  • Published on 03/06/2026 at 18:05, 4 hours 15 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 28/02/2026

  • Published on 03/06/2026 at 18:00, 4 hours 20 minutes ago

    Outstanding shares and voting rights statement at 28 February 2026

  • Published on 03/06/2026 at 18:00, 4 hours 20 minutes ago

    Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 28 février 2026

  • Published on 03/06/2026 at 18:00, 4 hours 20 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 février 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy